Skip to main content
Study

Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.

Balsom C, Pittman N, King R, et al. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial. Int J Clin Pharm. 2020:Epub Jun 3. doi:10.1007/s11096-020-01073-6.

Save
Print
July 1, 2020
Balsom C, Pittman N, King R, et al. Int J Clin Pharm. 2020:Epub Jun 3.

Polypharmacy is one risk factor for medication errors in older adults. This study describes the implementation of a pharmacist-administered deprescribing program in a long-term care facility in Canada. Over a one-year period, residents were randomized to receive either a deprescribing-focused medication review by a pharmacist or usual care. The intervention resulted in fewer medications taken by residents the intervention group after 6 months. Most deprescribing recommendations reflected a lack of ongoing indication or a dosage that was too high.

Save
Print
Cite
Citation

Balsom C, Pittman N, King R, et al. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial. Int J Clin Pharm. 2020:Epub Jun 3. doi:10.1007/s11096-020-01073-6.